CD24 and neoplasm: Recent reports demonstrated that a hybrid epithelial/mesenchymal CD44+/CD24-/ALDH+ CSC subpopulation is more tumorigenic then its pure counterpart, although its role in metastasis and secondary tumor formation remains to be elaborated [49–51].